Pantoprazol Farmalider (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Farmalider, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Farmalider as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Farmalider is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates ulcer healing and reduces recurrence. - Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer closure and prevents relapse. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.

Pantoprazol Farmalider is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional and self‑limiting. - Abdominal pain: mild discomfort. - Flatulence: gas‑related bloating. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may present with watery diarrhoea. - Acute interstitial nephritis: renal function monitoring recommended. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fractures (with long‑term use): increased risk of hip, wrist or spine fractures.

When prescribing Pantoprazol Farmalider, clinicians should consider several safety aspects. - Renal impairment: dose adjustment may be required. - Hepatic impairment: monitor for increased exposure. - Long‑term therapy: assess need periodically to avoid unnecessary exposure. - Concomitant use with NSAIDs: monitor for gastrointestinal bleeding. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazol Farmalider can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR values. - Digoxin: possible increase in serum concentrations. - Methotrexate (high dose): reduced renal clearance may raise toxicity risk.